Data as of 9:54am ET
| +0.0004 / +0.01%|
The 2 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 6.75, with a high estimate of 7.00 and a low estimate of 6.50. The median estimate represents a +3.84% increase from the last price of 6.50.
The current consensus among 2 polled investment analysts is to Buy stock in Sinovac Biotech Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.